(3R,4S)-1-Boc-3-amino-4-hydroxy-pyrrolidine, 95.0%, 1g

5-Bromo-2-fluoro-3-methylbenzonitrile, 98%, 1g

6,7-DIHYDROXYQUINAZOLIN-4(3H)-ONE, 95.0%, 1g

2,5-Dibromo-3-dodecylthiophene>97.0%(GC)5g

4-Chlorocinnoline, 95.0%, 1g

GC capillary column ROTI®Cap-5 MS, 25 m, 0.32 mm, 1.00 µm, 1 Piece(s)

6-(METHYLAMINO)NICOTINAMIDE, 95%, 250mg

Benzonitrile, 4-[2-(2-cyclopentylidenehydrazinyl)-4-thiazolyl]-, hydrobromide (1:1), 25mg

Dibenzoyl-L-tartaric acid, 98.0%, 25g

Ethyl 2-chloro-4-methylpyrimidine-5-carboxylate, 95.0%, 5g

4-Fluoro-3-methylbenzenesulfonyl chloride, 95.0%, 10g

2-Methyl-3-oxo-3,4-dihydro-2h-benzo[b][1,4]thiazine-6-carboxylic acid, 95+%, 100mg

Quinazoline>98.0%(GC)(T)1g